Nimmathota Arlappa

You are already at the latest version Background: Excess dietary sodium intake is a major modifiable risk factor for hypertension and cardiovascular disease (CVD) globally. Potassium-Enriched Low-Sodium Salt Substitutes (LSSS), which partially replace sodium chloride with potassium chloride, are recommended as a population-level sodium-reduction strategy. However, sensory acceptability remains a key barrier to their adoption, particularly in India where discretionary salt use predominates.

I read the correspondence by Sachdev et al. [1]. The contents were rather harsh, and they continued to present incorrect arguments to justify their decision to discontinue the universal VAS programme in India. The authors have deliberately avoided direct evidence-based responses to the queries raised in my previous correspondence [2].

Response to Letter to the Editor: This is a preview of subscription content, access via your institution Access options Subscribe to Journal Get full journal access for 1 year $119.00 only $9.92 per issue All prices are NET prices. VAT will be added later in the checkout. Tax calculation will be finalised during checkout. Buy article Get time limited or full article access on ReadCube. $32.00 All prices are NET prices.